Tag: Competition

Displaying 121 - 140 of 2499 results.

Pages

The Federal Trade Commission will require CentraCare Health, a healthcare provider in St. Cloud, Minnesota, to release some physicians from “non-compete” contract clauses, allowing them to join competing practices, under a settlement mitigating likely anticompetitive effects from CentraCare’s...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that ON Semiconductor Corporation’s $2.4 billion acquisition of Fairchild Semiconductor International, Inc. is likely anticompetitive.
At a public hearing in Abingdon, Virginia, held today, FTC staff presented oral remarks to the Southwest Virginia Health Authority and the Virginia Department of Health summarizing staff’s analyses and conclusions that the cooperative agreement application submitted by Mountain States Health...
FTC staff submitted a comment to the Southwest Virginia Health Authority and the Virginia Department of Health opposing the cooperative agreement application submitted by Mountain States Health Alliance and Wellmont Health System. “The proposed merger presents substantial risk of...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Fortiline, LLC, a company that distributes ductile iron pipe, fittings and accessories throughout much of the United States, illegally invited a competitor to collude on prices.
In testimony presented to the U.S. Senate Committee on Commerce, Science, and Transportation, the Federal Trade Commission described its work, and called for several changes to the FTC Act that would enhance its ability to protect consumers and promote competition.
The Federal Trade Commission is currently accepting public comments on an application from HeidelbergCement AG and Italcementi S.p.A. to sell the Martinsburg, W.Va.-based Martinsburg Cement Business.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Teva Pharmaceutical Industries Ltd.’s $40.5 billion acquisition of Allergan plc’s generic pharmaceutical business would be anticompetitive.
Brief of the United States Department of Justice and the Federal Trade Commission as amici curiae, urging the Fifth Circuit to dismiss the appeal for lack of jurisdiction or, if the Court finds jurisdiction, to reject application of the state action doctrine to this case because the...

Pages